Cannara Biotech Inc. (LOVE.V) TSXV

1.92

+0.01(+0.52%)

Updated at August 18 03:59PM

Currency In CAD

Valuation

Market Cap61.25M
Enterprise Value102.95M
P/E Ratio12.98
PEG Ratio0.13
Price/Sales Ratio1.86
Price/Book Ratio1.85
Enterprise/Revenue2.33
Enterprise/EBITDA9.17

Fiscal Year

Fiscal YearAugust 31, 2024
Most Recent QuarterFebruary 28, 2025

Profitability

Profit Margin0.14
Operating Margin0.2

Management Effectiveness

Return On Assets0.08
Return On Equity0.15

Income Statement

Revenue81.75M
Revenue/Share1.04
Gross Profit29.79M
EBITDA15.16M
Net Income6.44M
Diluted EPS0.07

Balance Sheet

Total Cash5.06M
Total Cash/Share0.06
Total Debt48.86M
Total Debt/Equity0.52
Current Ratio2.35
Book Value Per Share1.04

Price History

52-Week Change190.91
52-Week High1.99
52-Week Low0.57
Moving Average 50 Days1.61
Moving Average 200 Days1.2

Statistics

Average Volume90,137
Shares Outstanding91.43M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateFebruary 13, 2023